In tandem, the company expands into Europe through partnerships with leading research and medical institutions to help them predict and prevent cancer relapse.

Eppendorf Xplorer plus can now tackle entire columns and rows of a 384-well plate in one single step.

Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids™ Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture.

This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours.

Uniqsis announces its PhotoSyn™ high-power photoreactor light module for continuous flow chemistry is now available with alternative LED array configurations.

Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells.

Winner is a postdoctoral fellow at Massachusetts Institute of Technology (MIT).

He succeeds Dr. Michael Schroeder, who resigned for personal reasons.

New antibody purification robots support further company growth.

Recognizing the escalating incidence of lung cancer in China, Owlstone Medical and Renji Hospital have a mutual interest in developing and making accessible diagnostics for the early detection of disease.